Mørk A - Search Results

1

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.

Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mørk A, Honig G, Bøgesø KP, Westerink BH, den Boer H, Wikstrom HV, Tecott LH. Cremers TI, et al. Among authors: mork a. Neuropsychopharmacology. 2004 Oct;29(10):1782-9. doi: 10.1038/sj.npp.1300474. Neuropsychopharmacology. 2004. PMID: 15138437

2

Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.

Cremers TI, Rea K, Bosker FJ, Wikström HV, Hogg S, Mørk A, Westerink BH. Cremers TI, et al. Among authors: mork a. Neuropsychopharmacology. 2007 Jul;32(7):1550-7. doi: 10.1038/sj.npp.1301287. Epub 2007 Jan 3. Neuropsychopharmacology. 2007. PMID: 17203017

3

Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

Sotty F, Folgering JH, Brennum LT, Hogg S, Mørk A, Hertel P, Cremers TI. Sotty F, et al. Among authors: mork a. Neuropharmacology. 2009 Jul;57(1):18-24. doi: 10.1016/j.neuropharm.2009.03.016. Epub 2009 Apr 17. Neuropharmacology. 2009. PMID: 19376075

Interestingly, blockade of 5-HT(2C) receptors significantly potentiates the effect of citalopram, a selective serotonin reuptake inhibitor, on serotonin efflux in the hippocampus and prefrontal cortex (Cremers, T.I.F.H., Giorgetti, M., Bosker, F.J., Hogg, S., Arnt, J., …

Interestingly, blockade of 5-HT(2C) receptors significantly potentiates the effect of citalopram, a selective serotonin reuptake inhi …

4

Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram.

Cremers TI, Spoelstra EN, de Boer P, Bosker FJ, Mørk A, den Boer JA, Westerink BH, Wikström HV. Cremers TI, et al. Among authors: mork a. Eur J Pharmacol. 2000 Jun 2;397(2-3):351-7. doi: 10.1016/s0014-2999(00)00308-3. Eur J Pharmacol. 2000. PMID: 10844134

5

Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

Mørk A, Witten LM, Arnt J. Mørk A, et al. Psychopharmacology (Berl). 2009 Sep;206(1):39-49. doi: 10.1007/s00213-009-1578-4. Epub 2009 Jun 9. Psychopharmacology (Berl). 2009. PMID: 19506838

6

Involvement of presynaptic 5-HT_1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats.

Mombereau C, Arnt J, Mørk A. Mombereau C, et al. Among authors: mork a. Pharmacol Biochem Behav. 2017 Feb;153:141-146. doi: 10.1016/j.pbb.2016.12.015. Epub 2017 Jan 3. Pharmacol Biochem Behav. 2017. PMID: 28057524

7

Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram.

Husum H, Mikkelsen JD, Hogg S, Mathé AA, Mørk A. Husum H, et al. Among authors: mork a. Neuropharmacology. 2000 Jun 8;39(8):1463-73. doi: 10.1016/s0028-3908(00)00009-5. Neuropharmacology. 2000. PMID: 10818262

8

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB. Bang-Andersen B, et al. Among authors: mork a. J Med Chem. 2011 May 12;54(9):3206-21. doi: 10.1021/jm101459g. Epub 2011 Apr 12. J Med Chem. 2011. PMID: 21486038

9

Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.

Maeda K, Sugino H, Akazawa H, Amada N, Shimada J, Futamura T, Yamashita H, Ito N, McQuade RD, Mørk A, Pehrson AL, Hentzer M, Nielsen V, Bundgaard C, Arnt J, Stensbøl TB, Kikuchi T. Maeda K, et al. Among authors: mork a. J Pharmacol Exp Ther. 2014 Sep;350(3):589-604. doi: 10.1124/jpet.114.213793. Epub 2014 Jun 19. J Pharmacol Exp Ther. 2014. PMID: 24947465

10

Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol.

Witten L, Bastlund JF, Glenthøj BY, Bundgaard C, Steiniger-Brach B, Mørk A, Oranje B. Witten L, et al. Among authors: mork a. Neuropsychopharmacology. 2016 Jan;41(2):638-45. doi: 10.1038/npp.2015.194. Epub 2015 Jul 1. Neuropsychopharmacology. 2016. PMID: 26129678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page